This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Dec 20;26(36):6009-10; author reply 6010-1.

doi: 10.1200/JCO.2008.19.4886. Epub 2008 Nov 17.

"Groovy" vaccine for melanoma--but which groove?

Sandra L Nehlsen-Cannarella

PMID: 19018078
DOI: 10.1200/JCO.2008.19.4886

Comment

"Groovy" vaccine for melanoma--but which groove?

Sandra L Nehlsen-Cannarella. J Clin Oncol. 2008.

. 2008 Dec 20;26(36):6009-10; author reply 6010-1.

doi: 10.1200/JCO.2008.19.4886. Epub 2008 Nov 17.

Author

Sandra L Nehlsen-Cannarella

PMID: 19018078
DOI: 10.1200/JCO.2008.19.4886

No abstract available

PubMed Disclaimer

Comment on

Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
Sosman JA, Carrillo C, Urba WJ, Flaherty L, Atkins MB, Clark JI, Dutcher J, Margolin KA, Mier J, Gollob J, Kirkwood JM, Panka DJ, Crosby NA, O'Boyle K, LaFleur B, Ernstoff MS. Sosman JA, et al. J Clin Oncol. 2008 May 10;26(14):2292-8. doi: 10.1200/JCO.2007.13.3165. J Clin Oncol. 2008. PMID: 18467720 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information